Page last updated: 2024-10-30

kynurenic acid and Anochlesia

kynurenic acid has been researched along with Anochlesia in 2 studies

Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kretschmer, BD1
Winterscheid, B1
Danysz, W1
Schmidt, WJ1
UrbaƄska, E1
Ikonomidou, C1
Sieklucka, M1
Turski, WA1

Other Studies

2 other studies available for kynurenic acid and Anochlesia

ArticleYear
Glycine site antagonists abolish dopamine D2 but not D1 receptor mediated catalepsy in rats.
    Journal of neural transmission. General section, 1994, Volume: 95, Issue:2

    Topics: Animals; Benzazepines; Catalepsy; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol;

1994
Aminooxyacetic acid produces excitotoxic lesions in the rat striatum.
    Synapse (New York, N.Y.), 1991, Volume: 9, Issue:2

    Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Aminooxyacetic Acid; Animals; Behavior, Animal; Catalepsy;

1991